| Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
|---|
| 01/08/2002 | CA2031578C Process for the preparation of molluscicidal 2,4,5-tribromopyrrole-3-carbonitrile compounds |
| 01/03/2002 | WO2002000661A1 PYRROLO[2,3-d]PYRIMIDINE COMPOUNDS AS IMMUNOSUPPRESSIVE AGENTS |
| 01/03/2002 | WO2002000650A2 Novel compounds possessing antibacterial, antifungal or antitumor activity |
| 01/03/2002 | WO2002000606A1 Biphenyl compound |
| 01/03/2002 | WO2001070693A3 Difluorobutyric acid derivatives and their use as metalloprotease inhibitors |
| 01/03/2002 | WO2000061549A3 Pharmaceutical compounds |
| 01/03/2002 | WO2000050470A3 Catalysts containing n-pyrrolyl substituted nitrogen donors |
| 01/03/2002 | US20020002199 Suitable for treating type I diabetes, type II diabetes, impaired glucose tolerance, insulin resistance or obesity |
| 01/03/2002 | US20020002195 Pesticidal 1-polyarylpyrazoles |
| 01/03/2002 | US20020002182 Cis-substituted aminocyclopropane derivatives |
| 01/03/2002 | US20020002171 Materials and methods for killing nematodes and nematode eggs |
| 01/03/2002 | US20020002168 Heterocyclic carboxamides |
| 01/03/2002 | US20020002158 Potentiation of glutamate receptor function; treating central nervous system disorders |
| 01/03/2002 | US20020002152 Methionine aminopeptidase type 2 inhibitors; n'-((2S,3R)-3-amino-2-hydroxy-5-(isopropylsulfanyl)pentanoyl)-3-chloro benzoyl hydrazide |
| 01/03/2002 | CA2414512A1 Novel compounds possessing antibacterial, antifungal or antitumor activity |
| 01/03/2002 | CA2413683A1 Fused cyclic compounds as modulators of nuclear hormone receptor function |
| 01/02/2002 | EP1167351A1 Process for the removal of hydrogen chloride from N-alkyl-2-pyrrolidone by azeotropic distillation |
| 01/02/2002 | EP1165564A2 Process for preparing inhibitors of nucleoside metabolism |
| 01/02/2002 | EP1165547A1 Substituted benzoylpyrazoles as herbicides |
| 01/02/2002 | EP1165546A2 Novel lactam inhibitors of matrix metalloproteinases, tnf-alpha, and aggrecanase |
| 01/02/2002 | EP1165534A2 Benzoylguanidine derivatives with advantageous properties, method for producing them and their use in the production of medicaments |
| 01/02/2002 | EP1165512A2 Method for arylating aza-heterocycles with activated aromatic compounds in the presence of cesium carbonate |
| 01/02/2002 | EP1165511A2 Method of producing heterocyclic carbamates from aza-heterocyclic compounds and carbon dioxide |
| 01/02/2002 | EP1165510A1 1-arenesulfonyl-2-aryl-pyrrolidine and piperidine derivatives for the treatment of cns disorders |
| 01/02/2002 | EP1165509A1 Method of producing 3,4-dihydroprolines and 3,4-dehydropiperidines |
| 01/02/2002 | EP1165508A1 Anticancer calcium channel blockers |
| 01/02/2002 | EP1165505A1 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| 01/02/2002 | EP1165504A2 INHIBITORS OF LFA-1 BINDING TO ICAMs AND USES THEREOF |
| 01/02/2002 | EP1165501A1 Alkenyl- and alkynyl-containing metalloprotease inhibitors |
| 01/02/2002 | EP1165500A1 Amide derivatives as inhibitors of matrix metalloproteinases,tnf-alpha,and aggrecanase |
| 01/02/2002 | EP0996627A4 Method for solution phase synthesis of oligonucleotides and peptides |
| 01/02/2002 | EP0817789B1 Bis-maleimido cross-linking agents |
| 01/02/2002 | CN1329593A N-substituted 2-cyanopyrrolidines |
| 01/02/2002 | CN1328824A Compound for curing female sexual disorder |
| 01/01/2002 | US6335444 Amino alcohol derivative and method for preparing the same |
| 01/01/2002 | US6335358 Lactacystin analogs |
| 01/01/2002 | US6335334 Hypertensive agents, anticoagulants; cardiovascular and sexual disorders, angina pectoris, and atherosclerosis |
| 12/27/2001 | WO2001098273A1 Novel compounds |
| 12/27/2001 | WO2001098272A1 Novel compounds |
| 12/27/2001 | WO2001098270A2 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 12/27/2001 | WO2001098269A2 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 12/27/2001 | WO2001098268A2 Piperidine amides as modulators of chemokine receptor activity |
| 12/27/2001 | WO2001097810A2 Use of therapeutic benzamide derivatives |
| 12/27/2001 | WO2001097790A2 Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and alkylating agents |
| 12/27/2001 | WO2001097751A2 New formulation comprising a betablocker and optionally a cholesterol-lowering agent |
| 12/27/2001 | WO2001097618A2 Combined therapy against tumors comprising substituted acryloyl distamycin derivatives, taxanes and/or antimetabolites |
| 12/27/2001 | US20010056123 Benzamidine derivatives |
| 12/27/2001 | US20010056113 Methods for the inhibition of angiogenesis with 6-amino EM-12 |
| 12/27/2001 | US20010056107 Cyano and carboxy derivatives of substituted styrenes are inhibitors of tumor necrosis factor alpha , nuclear factor kappa B, and phosphodiesterase and can be used to treat cachexia, endotoxic shock, inflammatory conditions etc. |
| 12/27/2001 | US20010056103 Non-immunosuppressive, piperidino or pyrrolidino amide derivative has an affinity for an FKBP-type immunophilin, useful for treating Alzheimer's Disease, Huntington's Disease, Parkinson's Disease, amyotrophic lateral sclerosis |
| 12/27/2001 | US20010056096 Administering to a patient suffering from hypercholesterolemia, hyperlipedimea and other metabolic disorders an effective amount of hydrozone, oxime or imine derivatives |
| 12/27/2001 | US20010054207 p-aminophenol derivative compounds and dye compositions containing same |
| 12/27/2001 | CA2413421A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 12/27/2001 | CA2413418A1 Piperidine amides as modulators of chemokine receptor activity |
| 12/27/2001 | CA2413274A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 12/27/2001 | CA2412054A1 Combined therapy against tumors comprising substituted acryloyl distamycin derivatives, taxanes and/or antimetabolites |
| 12/27/2001 | CA2411255A1 Novel compounds |
| 12/27/2001 | CA2411100A1 New formulation comprising a betablocker and optionally a cholesterol-lowering agent |
| 12/26/2001 | CN1328546A Pyrrolidines as inhibitors of neuraminidases |
| 12/26/2001 | CN1328452A Use of benzoylguanidines for treatment of non-insulin-dependent diabetes mellitus |
| 12/25/2001 | US6333425 Ionic compounds derived from malononitrile in which anionic charge is delocalized; excellent properties of solubility and dissociation |
| 12/25/2001 | US6333340 Sulfonamides with oxo, ester or amide groups for vision defects and cognition activators |
| 12/25/2001 | US6333339 3-Benzylpiperidine |
| 12/25/2001 | US6333337 Potassium channel inhibitors |
| 12/25/2001 | CA2068590C Process and intermediates for the preparation of spiro¬isoquinoline-4(1h),3'-pyrrolidine|-1,2',3,5'(2h)-tetrones which are useful as aldose reductase inhibitors |
| 12/20/2001 | WO2001096345A1 Tetrapyrroles |
| 12/20/2001 | WO2001096323A1 Serine protease inhibitors |
| 12/20/2001 | WO2001096304A1 Serine protease inhibitors |
| 12/20/2001 | WO2001096303A1 Serine protease inhibitors |
| 12/20/2001 | WO2001096298A2 1,2,4-trisubstituted benzenes as inhibitors of 15-lipoxygenase |
| 12/20/2001 | WO2001096297A2 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| 12/20/2001 | WO2001096296A1 Serine protease inhibitors |
| 12/20/2001 | WO2001096295A2 2-cyanopyrrolidine derivatives and their use as medicaments |
| 12/20/2001 | WO2001087838A8 Cyclohexane derivatives and their use as therapeutic agents |
| 12/20/2001 | WO2001062245A3 Bilirubin or biliverdin degradation fragments |
| 12/20/2001 | WO2001051456A3 Antibacterial agents |
| 12/20/2001 | US20010053855 Modified alkoxycarbonyloxypyridine as oligonucleotide blocking agent |
| 12/20/2001 | CA2719176A1 2-cyanopyrrolidine derivatives and their use as medicaments |
| 12/20/2001 | CA2412623A1 Tetrapyrroles |
| 12/20/2001 | CA2412618A1 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| 12/20/2001 | CA2411805A1 Serine protease inhibitors |
| 12/20/2001 | CA2411798A1 Serine protease inhibitors |
| 12/20/2001 | CA2411495A1 1,2,4-trisubstituted benzenes as inhibitors of 15-lipoxygenase |
| 12/19/2001 | EP1163237A1 Amide derivatives |
| 12/19/2001 | EP1163236A1 Aromatic heterocyclic compounds as anti-inflammatory agents |
| 12/19/2001 | EP1163218A1 New salt of (2r,3r,4r)-3,4-dihydroxy-2-hydroxymethylpyrrolidine |
| 12/19/2001 | EP1163217A1 New salt of (2r,3r,4r)-3,4-dihydroxy-2-hydroxymethylpyrrolidine |
| 12/19/2001 | EP1163215A1 Amino-thio-acrylonitriles as mek inhibitors |
| 12/19/2001 | EP1163211A1 Method for acylating peptides and novel acylating agents |
| 12/19/2001 | EP1163209A1 Compounds and compositions for delivering active agents |
| 12/19/2001 | EP1163208A2 Caspase inhibitors and uses thereof |
| 12/19/2001 | EP1102592A4 Coumarin and related aromatic-based polymeric prodrugs |
| 12/19/2001 | EP0813520B1 Arylsulfonylamino hydroxamic acid derivatives |
| 12/19/2001 | CN1327383A Pharmaceutical for treatment of neurological and neuropsychiatric disorders |
| 12/18/2001 | USRE37478 1-(arylthioalkyl, arylaminoalkyl, or arylmethylenealkyl)-4-(heteroaryl)piperazines and related compounds useful as antipsychotics and analgesics |
| 12/18/2001 | US6331640 Diaminopropionic acid derivatives |
| 12/18/2001 | US6331636 Treatment of central nervous system disorders, diabetes, hypertension, impotency, appetite control |
| 12/18/2001 | US6331623 Pyrrolothiazine and pyrrolothiazepine compounds having serotonin-2 receptor antagonistic and alpha-1-blocking action |
| 12/18/2001 | US6331564 Use of triaryl methane compounds for inhibiting unwanted cellular proliferation associated with inflammatory disease |
| 12/18/2001 | US6331563 N-Hydroxy-2-(Alkyl, Aryl, or Heteroaryl, Sulfanyl, Sulfinyl or Sulfonyl)-3-Substituted Alkyl, Aryl or Heteroarylamides as Matrix Metalloproteinase inhibitors |